Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Loeys-Dietz syndrome is a genetic connective tissue disorder caused by mutations in genes involved in the TGF-β (transforming growth factor-beta) signaling pathway. These mutations disrupt the body's ability to maintain healthy connective tissue, leading to widespread vascular and skeletal complications. What causes Loeys-Dietz syndrome? Loeys-Dietz syndrome is caused by pathogenic variants (mutations) in specific genes that regulate the TGF-β signaling pathway, which acts as a molecular "blueprint" for building and repairing connective tissue.
3 people with Loeys Dietz syndrome have shared their first-person experience on this question at DiseaseMaps.
TL;DR: Loeys-Dietz syndrome is a genetic connective tissue disorder caused by mutations in genes involved in the TGF-β (transforming growth factor-beta) signaling pathway. These mutations disrupt the body's ability to maintain healthy connective tissue, leading to widespread vascular and skeletal complications.
Loeys-Dietz syndrome is caused by pathogenic variants (mutations) in specific genes that regulate the TGF-β signaling pathway, which acts as a molecular "blueprint" for building and repairing connective tissue. When these genes do not function correctly, the signaling pathway becomes dysregulated, causing structural weakness in the aorta, arteries, and skeletal system. Currently, researchers have identified mutations in six primary genes associated with Loeys-Dietz syndrome: TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3, and SMAD2.
Yes, Loeys-Dietz syndrome is inherited in an autosomal dominant pattern. This means that a person only needs one copy of the mutated gene from one parent to develop the condition. However, it is important to note that many cases of Loeys-Dietz syndrome occur as a "de novo" or spontaneous mutation, meaning the mutation appears for the first time in an individual without a family history of the disorder.
The genetic architecture of Loeys-Dietz syndrome involves specific genes that govern protein production essential for vascular integrity. The following genes are currently recognized as the primary drivers of the condition:
While we understand that Loeys-Dietz syndrome stems from TGF-β signaling pathway dysfunction, the exact mechanism of how specific mutations lead to varying clinical severity remains an active area of research. Experts distinguish between the cause (the specific genetic mutation) and risk factors (which, for this condition, are almost exclusively genetic rather than environmental). Current research is focused on how these molecular pathways interact with blood pressure and environmental stressors to affect arterial health.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified physician regarding any medical condition.